POET Technologies Inc. - Form 20-F Summary (Fiscal Year Ended Dec 31, 2016)
Business Context and Reporting Period
Company: POET Technologies Inc. (Ontario, Canada)
Reporting Period: Fiscal year ended December 31, 2016
Business Model: Developer of opto-electronic and photonic fabrication processes, devices, and products. The company focuses on integrating photonics and electronics via monolithic (POET platform) and hybrid approaches.
Key Developments: In 2016, the company transitioned from a pure R&D entity to a commercial operator following the acquisition of two subsidiaries: DenseLight Semiconductor Pte. Ltd. (May 2016) and BB Photonics Inc. (June 2016). 100% of 2016 revenue was generated by DenseLight.
Key Financial Metrics
| Metric (US$) | 2016 | 2015 |
|---|---|---|
| Revenue | $1,861,747 | $0 |
| Gross Profit | $481,909 | $0 |
| Gross Margin | 26% | N/A |
| Net Loss | $(13,224,684) | $(12,070,170) |
| Operating Expenses | $14,196,980 | $12,070,170 |
| Cash and Short-Term Investments | $14,965,557 | $14,409,996 |
| Working Capital | $15,509,859 | $14,045,498 |
| Total Assets | $35,505,957 | $15,934,839 |
| Accumulated Deficit | $(104,075,356) | $(90,850,672) |
Non-Cash Items: Significant non-cash operating costs included $4,070,264 in stock-based compensation and $1,521,566 in depreciation and amortization.
Material Changes vs. Prior Period
- Revenue Generation: The company recorded its first-ever revenue ($1.86M) in 2016, entirely attributable to the DenseLight subsidiary acquired in May 2016. There was no revenue in 2015 or 2014.
- Acquisition Impact: Total assets more than doubled from 2015 to 2016 due to the acquisitions of DenseLight and BB Photonics, which added significant property, equipment, goodwill ($7.68M), and intangible assets.
- Expense Structure: Selling, marketing, and administration expenses increased by 31% to $11.26M, driven by acquisition costs, public offering expenses, and the integration of new subsidiaries. R&D expenses decreased slightly to $2.89M due to synergies and outsourcing, despite adding new R&D capabilities.
- Financing: The company raised approximately $11.78M net from equity financing (public offering and option/warrant exercises) in 2016.
Guidance, Outlook, and Risks
Outlook: Management expects to launch at least two new products in 2017 and anticipates revenue growth beyond 2016 levels. The company aims to transition from an R&D company to a commercial enterprise. Initial commercial revenues for new sensing products are expected in 2017, with monolithic photonic engine solutions targeted for late 2018.
Risks and Contingencies:
- Liquidity: The company has a history of losses and relies on equity financings. While current working capital is deemed sufficient beyond 2017, future funding may be required.
- Commercialization: The core POET technology has not yet been commercialized. Success depends on product qualification and market acceptance in the highly competitive semiconductor market.
- Acquisition Integration: DenseLight had a history of losses prior to acquisition; profitability is not guaranteed.
- Government Grants: The company receives funding from government agencies (e.g., Singapore EDB, US DoD). Failure to meet covenants could result in repayment obligations.
- Intellectual Property: Risks include the inability to protect patents or potential infringement claims.
Investor Verification Checklist
- Revenue Sustainability: Verify if the $1.86M revenue from DenseLight is recurring or project-based, and assess the timeline for commercializing the proprietary POET technology.
- Cash Burn Rate: Analyze the $13.2M net loss against the $15M cash position to determine the runway before additional equity financing is required.
- Acquisition Performance: Review the specific performance targets for DenseLight that triggered the $1M contingent consideration (which was adjusted to nil in 2016) and future targets.
- Stock-Based Compensation: Assess the impact of $4M+ in non-cash stock compensation on future cash flow and potential dilution from outstanding options and warrants.
- Government Funding: Confirm the status of the Singapore EDB grant agreement and any conditions attached to the $7.7M potential support.